Vectors
AAV Vectors Provide Basis for Safe/Efficient Ex Vivo Gene Therapy
Published in Gene Therapy Weekly, August 5th, 1996
The ability to insert transgenes into pluripotent hematopoietic stem cells could result in the ex vivo gene therapy treatment of several different diseases and disorders. Previous research with retroviral vectors has shown that hematopoietic cells can be transfected and will express the newly inserted gene product.
However, for efficient transduction with retroviral vectors, the stem cells must be stimulated into a state of division. Unfortunately, the cytokine-induced prestimulation results in the loss of the self-renewal capacity and also commits the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (1996-08-05)
More Articles from Gene Therapy Weekly
- Cancer Gene Therapy
Gene Transfer of WTp53 Induces Apoptosis in Cervical Cancer Model - Cancer Gene Therapy
Immunotherapy Possible with Particle-Mediated Cytokine Gene Transfer - Cancer Gene Therapy
Overexpression of Metalloproteinases-2 Inhibits Tumor Growth - AIDS Therapies (Liposomes)
HIV/AIDS CD4 Therapeutic Technology Licensed - Antisense Technology
Adenoviral-Mediated Antisense Gene Therapy Exhibits Antitumor Effects In Vivo - Arthritis
World's First Program Initiated at UPMC - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
